Bitcoin

Bitcoin
Bitcoin

Will XLM revisit $0.136 low as market turns bearish? Check forecast

Bitcoin, Ether, and XRP are all in the red as the broader cryptocurrency market shed billions in market cap over the last 24 hours.  The bearish performance has spread to other leading cryptocurrencies, with Stellar (XLM) down by nearly 2%.  XLM is trading below $0.1600 at the time of writing on Wednesday, extending its correction

Read More
Bitcoin

Commodity wrap: gold, oil, base metals surge on dollar weakness, supply risks

Gold prices rose more than 1% on Wednesday as a weaker dollar and falling bond yields boosted sentiment.  Gold prices climbed back over $5,100 per ounce, while silver rose more than 4% as investors digested key employment data from the US.  Meanwhile, oil prices also jumped more than 2%, with Brent hitting $70 per barrel

Read More
Bitcoin

US stocks open in the green after strong jobs data: Nasdaq climbs around 1%

US equities moved higher on Wednesday after a stronger-than-expected January jobs report eased concerns about slowing economic momentum and reinforced confidence in the resilience of the labour market. The Dow Jones Industrial Average rose 207 points, or about 0.4%. The S&P 500 gained 0.6%, while the Nasdaq Composite advanced 0.8%, as investors responded positively to

Read More
Bitcoin

Wall Street likes Reddit stock again: why analysts are backing bullish targets

Reddit stock (NYSE: RDDT) is once again drawing attention on Wall Street. After spending much of last year under a cloud of doubt over growth and monetisation, the social platform is seeing sentiment turn. This time, the shift is being driven less by hype and more by something investors care deeply about: clear signs that

Read More
Bitcoin

All about century bonds and why analysts back Alphabet’s 100-year bond 

If the scale of Big Tech’s AI spending plans for 2026 was not striking enough, Alphabet’s reported move to issue a rare 100-year bond has added a new dimension to the debate over how far tech giants are willing to go to finance the AI boom. Alphabet Inc. is preparing to sell a rare 100-year

Read More
Bitcoin

Broadcom stock: risky pattern emerges despite solid tailwinds

The Broadcom stock price has rebounded in the past few days, moving from a low of $295 last week to $345 today as investors cheer the recent plans for AI spending.  Still, the company remains in a technical bear market after falling by 16% from its highest level in 2025. It has also formed a

Read More
Bitcoin

HYPE sheds 18% in one week: will it retest the $27 support level?

HYPE, the native coin of the Hyperliquid DEX, has lost 18% of its value since hitting its yearly high of $38 last week. It has now dropped below $30 and could record further losses as the broader market continues to underperform.  The derivatives data further support this bearish sentiment, with rising short bets while funding

Read More
Bitcoin

Coca-Cola stock slumps as Q4 revenue misses estimates

Coca-Cola shares fell on Tuesday after the beverage giant reported quarterly revenue growth that came in below analysts’ expectations, overshadowing a modest earnings beat and early signs of stabilising demand in key markets. The company reported adjusted earnings of 58 cents per share for the fourth quarter, ahead of Wall Street estimates of 56 cents.

Read More
Bitcoin

Jupiter price slides below $0.15 amid technical breakdown

Jupiter (JUP), the governance token for the leading Solana-based decentralized exchange aggregator, has dropped to below $0.15 as it continues its downward spiral. As the broader cryptocurrency market heaves under fresh pressure, JUP slid 5% to revisit recent lows reached on February 5, 2026. JUP traded to these levels last week, and the retreat seen

Read More
Bitcoin

CVS Health beats expectations as turnaround strategy gains traction

CVS Health delivered a stronger-than-expected fourth quarter, beating Wall Street estimates on both earnings and revenue as the company presses ahead with a multi-year turnaround. The results underline a period of stabilisation after a challenging 2024, with management reaffirming long-term profit and revenue targets despite policy changes and pricing pressure across the healthcare sector. Investors

Read More